7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
` Menu
`
`
`
`
`
`
`
`
`
`22-25 JANUARY 2018 // MIAMI
`
`
`
`Twitter
`
`
`
`Linkedin
`
`
`
`YouTube
`
`
`
`Email
`
`ENQUIRE HERE
`
`SPONSORSHIP ENQUIRY
`
`Speakers
`
`Dr David Lebwohl
`
`Senior Vice President & Global Program Head, CAR-T Program, Novartis
`
`David Lebwohl, M.D. is Senior Vice President and Executive Global Program Head for the CART Team in the Novartis
`
`Cell and Gene Therapy Unit, based in East Hanover, NJ, USA. In this position he leads the development of chimeric
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`1/16
`
`Ex. 1079-0001
`
`
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
` Menu
`
`
`
`
`
`
`
`
`
`22-25 JANUARY 2018 // MIAMI
`
`
`
`
`
`
`
`
`
`YouTube
`
`
`
`
`ENQUIRE HERE
`
`SPONSORSHIP ENQUIRY
`
`Speakers
`
`Dr David Lebwohl
`
`Senior Vice President & Global Program Head, CAR-T Program, Novartis
`
`David Lebwohl, M.D. is Senior Vice President and Executive Global Program Head for the CART Team in the Novartis
`
`Cell and Gene Therapy Unit, based in East Hanover, NJ, USA. In this position he leads the development of chimeric
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`1/16
`
`Ex. 1079-0001
`
`
`
`7/27/2017
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`antigen receptor T-cell therapies at Novartis.
`
`He was formerly global head of Oncology Clinical Development, and Global Program Head for A nitor, an oral mTOR
`
`inhibitor, within Novartis Oncology. He graduated from Harvard College magna cum laude in Biochemical Sciences
`
`and was then a Graduate Research Student in Tumour Immunology at University College London. He graduated as
`
`doctor of medicine from the Yale University School of Medicine.
`
`Following post-graduate training at Brigham and Women’s Hospital and Memorial Sloan-Kettering Cancer Center in
`
`internal medicine, hematology and medical oncology, he joined the staff of Memorial Sloan-Kettering on the Breast
`
`Cancer Service. More recently, Dr. Lebwohl has focused on the clinical development of new cancer drugs, rst at
`
`Bristol Myers Squibb, where he lead the development of JM-216, an oral platinum, and ixabepilone, an epothilone, as
`
`well as other compounds. He joined Novartis Oncology in 2002 where he was responsible for the development of
`
`A nitor (RAD001) from phase 1 through ve NDA/MAA approvals. He also led the clinical development of PTK787, a
`
`VEGFR inhibitor, panobinostat, a deacetylase inhibitor, and PKC412, a FLT3 kinase inhibitor.
`
`Sessions
`
` 17-Jan-2017 18:00 - 19:30
`Afternoon Super Session (Shared with Immunotherapy World 2017): Changing Modern Medicine
`
` 18-Jan-2017 12:10 - 12:40
`A compare and contrast of the latest clinical data from - and the processes and materials used by - the T cell
`
`immunotherapy sector's most advanced pharma and biotech companies
`
`Featured Speakers
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`2/16
`
`Ex. 1079-0002
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`Martin Andrews
`Senior Vice President, Global Rare
`Diseases , GlaxoSmithKline
`
`Xavier Anguela
`Discovery Research Lead , Spark
`Therapeutics
`
`Naomi Aronson
`Executive Director of Clinical Evaluation,
`Innovation and Policy in the O ce of
`Clinical Affairs , Blue Cross and Blue
`Shield Association
`
`
`
`
`
`Attending pharma/biotech companies include
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`3/16
`
`Ex. 1079-0003
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`4/16
`
`Ex. 1079-0004
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`5/16
`
`Ex. 1079-0005
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`6/16
`
`Ex. 1079-0006
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`7/16
`
`Ex. 1079-0007
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`8/16
`
`Ex. 1079-0008
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`9/16
`
`Ex. 1079-0009
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`10/16
`
`Ex. 1079-0010
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`11/16
`
`Ex. 1079-0011
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`12/16
`
`Ex. 1079-0012
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`13/16
`
`Ex. 1079-0013
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`14/16
`
`Ex. 1079-0014
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`Event organiser
`
`Useful links
`
`Book a stand
`
`Brochure
`
`E-newsletter sign up
`
`Contact us
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`15/16
`
`Ex. 1079-0015
`
`
`
`7/27/2017
`
`David Lebwohl - Cell & Gene Therapy World 2017 - Meet the Future of Cell & Gene Therapy
`
`Next cell & gene therapy event
`
`Cell & Gene Therapy Europe
`20-21 September 2017 | Berlin, Germany
`
`Contact Details
`
`Sales enquiries
`Call +44(0)207 384 8027 or peter.harkness@phacilitate.co.uk
`
`
`
`Delegate enquiries
`Call +44(0)207 384 7993 or kim@phacilitate.co.uk
`
`© CLARION EVENTS LIMITED
`PRIVACY
`© COPYRIGHT 2016
`CONFERENCE WEBSITE BY ASP
`
`http://www.bioleaders-forum.com/speakers/david-lebwohl
`
`16/16
`
`Ex. 1079-0016
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
